Lack of effect of methotrexate in budesonide-refractory collagenous colitis
Authors:
Open Access
- 1 August 2013
- journal article
- case report
- Published by Taylor & Francis in Clinical and Experimental Gastroenterology
- Vol. 6, 149-152
Abstract
Background: In most cases, collagenous colitis can be treated effectively with budesonide. However, some patients develop side effects or have chronic symptoms refractory to budesonide. This paper reports an open case series of patients intolerant or refractory to budesonide who were treated with methotrexate (MTX). Methods and patients: Nine patients (seven women) with a median (range) age of 62 (44–77) years were studied. Bowel movements were registered during 1 week prior to baseline and after 6 and 12 weeks’ treatment, enabling calculation of the mean bowel movements/day. All patients underwent colonoscopy with biopsies before inclusion to confirm diagnosis. Open treatment with MTX was given 15 mg subcutaneously weekly for 6 weeks and was increased to 25 mg for a further 6 weeks if symptoms were unresponsive to the first 6 weeks’ treatment. The endpoint was clinical remission, which was defined as a mean Results: Five patients fulfilled the treatment according to the protocol and four patients discontinued the study after 3–6 weeks because of adverse events. No patient achieved clinical remission at Week 12. The mean stool frequency/day at baseline was 6.0 stools/day, thereof 5.4 watery stools/day and after 12 weeks treatment 6.4 stools/day, thereof 5.7 watery/day. No patient appreciated an improvement of health-related quality of life. Conclusion: Short-term treatment with MTX had no clinical effect in collagenous colitis patients intolerant or refractory to budesonide. Alternative therapies should be investigated in these patients.Keywords
This publication has 15 references indexed in Scilit:
- Interventions for Treating Microscopic Colitis: A Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group Systematic Review of Randomized TrialsAmerican Journal of Gastroenterology, 2008
- Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trialGut, 2008
- The epidemiology of microscopic colitis: a population based study in Olmsted County, MinnesotaGut, 2006
- Long‐term follow‐up of collagenous colitis after induction of clinical remission with budesonideAlimentary Pharmacology & Therapeutics, 2005
- Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Örebro, Sweden, 1993–1998Gut, 2004
- Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysisGut, 2003
- Budesonide treatment for collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trialGastroenterology, 2002
- `Microscopic colitis': classification and terminologyHistopathology, 2002
- Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-upGastroenterology, 2002
- Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurineGastroenterology, 2001